Syndecan-4 as a biomarker to predict clinical outcome for glioblastoma multiforme treated with WT1 peptide vaccine
暂无分享，去创建一个
K. Mizuguchi | N. Hosen | Y. Oji | A. Tsuboi | Y. Oka | H. Sugiyama | A. Kumanogoh | N. Hashimoto | N. Tatsumi | J. Nakata | S. Nishida | F. Fujiki | H. Nakajima | S. Morimoto | Y. Nakae | S. Takashima